24 results match your criteria: "Medical Center for Rheumatology Berlin Buch[Affiliation]"
Front Med (Lausanne)
December 2024
Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.
J Rheumatol
March 2024
G.A. Bruyn, MD, PhD Rheumatology, Reumakliniek Lelystad, Lelystad, and Tergooi MC Hospitals, Hilversum, the Netherlands.
Objective: To assess the construct validity of the novel Outcome Measures in Rheumatology (OMERACT) ultrasound (US) semiquantitative scoring system for morphological lesions in major salivary glands by comparing it with magnetic resonance imaging (MRI) and unstimulated whole salivary flow rates (U-WSFRs) in patients with primary Sjögren syndrome (pSS).
Methods: Nine sonographers applied the OMERACT 0-3 grayscale scoring system for parotid (PGs) and submandibular glands (SMGs) in 11 patients with pSS who also had MRIs performed. These were evaluated by 2 radiologists using a semiquantitative 0-3 scoring system for morphological lesions.
Best Pract Res Clin Rheumatol
March 2023
Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Lindenberger Weg 19, 13125 Berlin, Germany. Electronic address:
Rheumatologists are increasingly using vascular ultrasound. Several guidelines now recommend ultrasound as the first diagnostic modality in giant cell arteritis (GCA). The German curriculum for rheumatology training has recently included ultrasound for the acute diagnosis of vasculitis.
View Article and Find Full Text PDFJ Rheumatol
November 2022
W.A. Schmidt, MD, Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany.
BMC Med Imaging
March 2021
Clinic of Internal Medicine III, Department of Oncology, Haematology, Rheumatology and Clinical Immunology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Background: Giant cell arteritis (GCA) is the most common form of systemic vasculitis in persons aged 50 years and older. Medium and large vessels, like the temporal and axillary arteries, are commonly affected. Typical symptoms are headache, scalp tenderness, jaw claudication and ophthalmological symptoms as loss of visual field, diplopia or amaurosis due to optic nerve ischemia.
View Article and Find Full Text PDFArthritis Res Ther
October 2020
Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway.
Background: There has been a shift in recent years to using ultrasound (US) and magnetic resonance imaging (MRI) as first-line investigations for suspected cranial large vessel vasculitis (LVV) and is a new recommendation by the EULAR 2018 guidelines for imaging in LVV. This cross-sectional study compares the performance of US and MRI and contrast-enhanced magnetic resonance angiography (MRA) for detecting vasculitis in patients with giant cell arteritis (GCA).
Methods: Patients with new-onset or already diagnosed GCA were recruited.
J Rheumatol
October 2019
From the Department of Rheumatology, MC Groep hospitals, Lelystad, the Netherlands; Academic Rheumatology Centre, Università degli Studi di Torino, Turin; Department of Medical Sciences, Section of Rheumatology, University of Ferrara; Azienda Ospedaliero-Universitaria Sant'Anna di Cona, Ferrara, Italy; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid; Rheumatology Department, Paediatric Rheumatology Unit, Hospital Universitario Severo Ochoa, Madrid, Spain; Rheumatology Department, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary; Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitacion, Mexico City, Mexico; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin, Germany; Rheumatology Department, Cavale Blanche Hospital; Brest Occidentale University, Brest; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Boulogne-Billancourt, France; Department of Rheumatology, Medical University of Vienna, Vienna, Austria; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Rheumatology, University of Adelaide, Adelaide, Australia; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark.
Objective: The Outcome Measures in Rheumatology (OMERACT) Ultrasound (US) Working Group (WG) operates research activities for the validation of US as an outcome measurement instrument according to the Filter 2.0 framework.
Methods: Original publications on definitions and scoring systems for pathophysiological manifestations and elementary lesions of various rheumatic disorders were reviewed from the onset of the WG research in 2005.
J Rheumatol
August 2018
From the University Hospital Bonn III, Medical Clinic, Department of Oncology, Hematology and Rheumatology, Bonn; Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch, Berlin; Asklepios Medical Center, Bad Abbach, Germany; Hospital of Southwest Denmark, Esbjerg; Diagnostic Centre Region Hospital Silkeborg, Silkeborg; Odense University Hospital, Odense; Copenhagen Center for Arthritis Research (COPECARE), Glostrup, Denmark; Medical University Graz, Graz; Medical University Innsbruck, Innsbruck, Austria; Hospital of Bruneck, Bruneck; Università degli Studi di Torino, Turin; Epidemiology Unit - Italian Society for Rheumatology (SIR), Milan; Arcispedale Santa Maria Nuova, Reggio Emilia; University of Ferrara, Italy; MC Groep Hospitals, Lelystad; Leiden University Medical Center, the Netherlands; Hôpital Ambroise Paré, Boulogne-Billancourt, France; University Hospital La Paz, Madrid, Spain; Martina Hansens Hospital, Bærum, Oslo, Norway; University Medical Centre Ljubljana, Ljubljana, Slovenia; University of California at Los Angeles, Los Angeles, California; Mayo Clinic, Rochester, Minnesota, USA; Pomeranian Medical University, Szczecin, Poland; Norfolk and Norwich University Hospital, Norwich; Southend University Hospital, UK National Health Service (NHS) Foundation Trust and Anglia Ruskin University, Westcliff, UK; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculty of Medicine, University of Lisbon; Rheumatology Department, Hospital de Santa Maria - CHLN, Lisbon, Portugal.
J Rheumatol
November 2017
From the University of Siena, Siena; Italian Society for Rheumatology (SIR) Epidemiology Unit, Milan; University of Pisa, Pisa; Università Politecnica delle Marche, Jesi; Internal Medicine Division, San Jacopo Hospital, Pistoia; Università degli Studi di Torino, Turin, Italy; University of Belgrade, Belgrade, Serbia; Department of Rheumatology, MC Groep, Lelystad, the Netherlands; APHP, Hôpital Ambroise Paré, Rheumatology Department, Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, Saint-Quentin en Yvelines, France; Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, Mexico City, Mexico; Rehabilitation Clinical Hospital, Cluj-Napoca; Sf. Maria Hospital, Bucharest, Romania; Instituto Poal, University of Barcelona, Barcelona; Department of Rheumatology, Joint and Bone Research Unit, Hospital Universitario Fundación Jimenez Deaz and Autónoma University, Madrid, Spain; Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch Berlin, Berlin, Germany; Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Lausanne University Hospital, Lausanne, Switzerland.
Objective: To define the ultrasonographic characteristics of calcium pyrophosphate crystal (CPP) deposits in joints and periarticular tissues and to evaluate the intra- and interobserver reliability of expert ultrasonographers in the assessment of CPP deposition disease (CPPD) according to the new definitions.
Methods: After a systematic literature review, a Delphi survey was circulated among a group of expert ultrasonographers, who were members of the CPPD Ultrasound (US) Outcome Measures in Rheumatology (OMERACT) subtask force, to obtain definitions of the US characteristics of CPPD at the level of fibrocartilage (FC), hyaline cartilage (HC), tendon, and synovial fluid (SF). Subsequently, the reliability of US in assessing CPPD at knee and wrist levels according to the agreed definitions was tested in static images and in patients with CPPD.
J Rheumatol
November 2017
From the Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen; Department of Rheumatology, Zealand's University Hospital, Køge, Denmark; Dipartimento Scienze Cliniche e Biologiche - Reumatologia, Università degli Studi di Torino, Turin; Department of Medicine, Surgery and Neurosciences, Rheumatology Section, University of Siena, Siena; Pediatric Rheumatology Unit, IRCCS Ospedale Pediatrico Bambino Gesù, Rome; Internal Medicine Department, Azienda Socio Sanitaria Territoriale di Mantova, C. Poma Hospital, Mantua, Italy; Department of Rheumatology, MC Groep, Lelystad; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, Joint and Bone Research Unit, Hospital Universitario Fundación Jiménez Díaz; Autónoma University; Hospital Universitario Severo Ochoa, Madrid, Spain; Clinic Center, Faculty of Medicine, University of Niš, Niš; Institute of Rheumatology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Rheumatology Research Group, The University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Freiburg, Freiburg; Charite University Hospital, Humboldt University; Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin-Buch; Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany; APHP, Department of Rheumatology, CHU Pitie-Salpetriere, Paris 6 University, GRC-UPMC 08, Pierre Louis Institute of Epidemiology and Public Health; APHP, Hôpital Ambroise Paré, Rheumatology Department, 92100 Boulogne-Billancourt; INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University, 78180 Saint-Quentin en Yvelines, Paris, France; Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan; Department of Rheumatology, Royal Perth Hospital, Perth, Australia; Instituto Nacional de Rehabilitacion, Mexico City, Mexico; Rheumatology Institute of Rheumatology and Orthopedics, Royal Prince Alfred Hospital, Camperdown, Australia; Department of Rheumatology, Université catholique de Louvain, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires Saint Luc, Brussels, Belgium.
Objective: To provide an update from the Outcome Measures in Rheumatology (OMERACT) Ultrasound Working Group on the progress for defining ultrasound (US) minimal disease activity threshold at joint level in rheumatoid arthritis (RA) and for standardization of US application in juvenile idiopathic arthritis (JIA).
Methods: For minimal disease activity, healthy controls (HC) and patients with early arthritis (EA) who were naive to disease-modifying antirheumatic drugs were recruited from 2 centers. US was performed of the hands and feet, and scored semiquantitatively (0-3) for synovial hypertrophy (SH) and power Doppler (PD).
Ann Rheum Dis
October 2015
Department of Rheumatology, Southend University Hospital, Southend, UK.
Arthritis Rheumatol
October 2015
Southend University Hospital, Department of Rheumatology, Essex, UK.
Clin Exp Rheumatol
June 2013
Immanuel Krankenhaus Berlin, Medical Center for Rheumatology Berlin Buch, Berlin, Germany.
Objectives: The aim of the present paper is to determine if the ultrasound of hands and feet is comparable to the MRI of the dominant hand to detect erosive disease and inflammation in mild or moderate rheumatoid arthritis (RA).
Methods: Twenty-six patients (14 females; mean age, 48 years) with active mild or moderate RA (mean DAS28, 3.9; mean disease duration, 19 months) were examined clinically, by ultrasound and by gadolinium-enhanced low-field MRI at baseline, after 6 and 12 months (78 examinations).
Objective: Modern ultrasound (US) equipment allows rheumatologists to directly visualize hand and finger arteries. How does US aid in diagnosis of Raynaud's phenomenon (RP)?
Methods: Color Doppler US of the proper and common palmar digital, radial, and ulnar arteries and the superficial palmar arch of both hands was performed in 135 consecutive patients who presented with suspected RP.
Results: US was pathologic in 63% of patients with secondary RP, in 6% with primary RP, and in none with pseudo-RP (p < 0.
Front Neurol Neurosci
May 2007
Medical Center for Rheumatology Berlin-Buch, Berlin, Germany.
Takayasu and temporal arteritis are primary large-vessel vasculitides. Ultrasound directly depicts the inflamed vessel wall, which is homogenously and circumferentially thickened. Furthermore, stenoses and occlusions occur.
View Article and Find Full Text PDFJ Rheumatol
January 2007
Medical Center for Rheumatology Berlin-Buch, Immanuel Diakonie Group, Karower Str. 11, 13125 Berlin, Germany.
Autoimmunity
June 2006
Medical Center for Rheumatology Berlin-Buch, Karowerstr 11, Berlin 13 125, Germany.
The histopathologic analysis of the synovial tissue is important to distinguish rheumatoid arthritis (RA) from other forms of synovitis and to provide information about prognosis and therapeutic strategies at early stages of the disease. In this context, the present study was performed to investigate the correlation between immunohistopathological and morphological features of synovitis and the expression of collagenase 3 (MMP-13) known to contribute significantly to cartilage degradation in RA. In the histopathologic scoring system used in this study, type I synovitis is characterized by B lymphocyte infiltration and an intact lining, and is only mild destructive to cartilage and bone.
View Article and Find Full Text PDFCurr Treat Options Cardiovasc Med
April 2006
Medical Center for Rheumatology Berlin-Buch, Karower Str. 11, Berlin 13125, Germany.
Corticosteroid treatment should start directly after suspected diagnosis. The diagnosis should be confirmed within the next 5 days by histology or ultrasound. Clinical assessment includes auscultation of the axillary arteries in the search for large-vessel giant cell arteritis.
View Article and Find Full Text PDFRheumatol Int
August 2006
Medical Center for Rheumatology Berlin-Buch, Karower Str. 11, 13 125 Berlin, Germany.
Articular symptoms are frequent manifestations of hereditary haemochromatosis. The clinical signs of the arthropathy of haemochromatosis are not specific and difficult to identify in case of co-incidence of haemochromatosis with Heberden's and Bouchard's osteoarthritis or rheumatoid arthritis (RA). Here the manifestation of RA in a patient is reported who was successfully treated for haemochromatosis.
View Article and Find Full Text PDFPurpose Of Review: Ultrasonography and positron emission tomography have been increasingly studied and, in part, introduced in clinical practice to diagnose large-vessel vasculitides, such as temporal arteritis, Takayasu arteritis, large-vessel giant cell arteritis, and isolated aortitis.
Recent Findings: Ultrasonography reveals characteristic homogenous, concentric wall thickening in vasculitis, often combined with stenoses and, less frequently, with acute occlusions. Thirteen studies describe sensitivities of 40 to 100% (median, 86%) for temporal artery vessel wall edema compared with histology, and of 35 to 86% (median, 70%) compared with clinical diagnosis.
Curr Rheumatol Rep
June 2004
Medical Center for Rheumatology Berlin-Buch, Karower Strasse 11, D-13125 Berlin, Germany.
Imaging studies are necessary to determine disease extension and disease activity in the small-vessel vasculitides. Computed tomography (CT) and magnetic resonance imaging (MRI) increase the number of pathologic findings compared with conventional radiography. MRI delineates mucosal inflammation and granulomas in the paranasal sinuses, whereas CT provides information about osseous lesions.
View Article and Find Full Text PDFClin Exp Rheumatol
January 2003
Medical Center for Rheumatology Berlin-Buch, Berlin, Germany.
Objective: To investigate the involvement of arteries other than the temporal arteries in active giant cell arteritis using color Doppler sonography.
Methods: The occipital, facial, vertebral, carotid, subclavian, axillary, brachial, ulnar radial, femoral, popliteal, posterior tibial, and dorsal pedal arteries, and the abdominal aorta of 33 consecutive patients with acute giant cell arteritis and 33 age- and sex-matched controls were investigated.
Results: In 10 patients (30%), but in none of the controls, a characteristic inflammatory mural thickening (halo) could be demonstrated in these arteries.
Scand J Rheumatol
March 2001
Medical Center for Rheumatology Berlin-Buch, Klinikum Buch, Berlin, Germany.
A 37-year old male with newly diagnosed, untreated Wegener's granulomatosis including glomerulonephritis, sinusitis, conjunctivitis, arthralgias, and positive cANCA, developed a pulsating tumor in the left submandibular region and a reversible ischemic neurologic deficit. Ultrasonography revealed both a hyperechoic wall thickening of the left proximal internal carotid artery as is known in Takayasu's arteritis and a surrounding hypoechoic region typical for perivasculitis. The wall thickening and the perivascular infiltrate could be less clearly seen by MRI.
View Article and Find Full Text PDFIn a patient with active extracranial giant cell arteritis, duplex ultrasonography demonstrated hypoechoic mural thickening of the brachial, axillary, subclavian, and carotid arteries with bilateral subtotal occlusions of the brachial and axillary arteries. The ultrasound image of the artery walls became midechoic within 8 weeks, and hyperechoic within one year after start of treatment with corticosteroids. A similar hypoechoic mural thickening of the temporal arteries has been recently described in active giant cell arteritis.
View Article and Find Full Text PDF